Fundamentos en el manejo terapéutico actual de la insuficiencia cardíaca crónica

Abstract

Heart failure is currently a serious public health problem, the main risk factors for the development of HF are functional and structural heart disease, arterial hypertension, diabetes mellitus, obesity, as well as unhealthy habits such as sedentary lifestyle, diets rich in carbohydrates and saturated fats, consumption of tobacco, alcohol, cocaine, every day the incidence of this syndrome is greater, because this condition has a tendency to develop in advanced ages, becoming one of the main causes of hospitalizations in adults over 65 years. Therefore, it is of great importance to know the updated guidelines in the therapeutic management of this syndrome. Objective: The purpose of this review is to describe the current therapeutic guidelines in the management of chronic heart failure, through a bibliographic review, which serves as a support tool in the management of this nosological entity. Methods: For the development of this research in order to develop an updated tool in the therapeutic management of HF, a search was made for scientific articles published in the last 5 in the PubMed, LILACS, and data centers of the Ecuador. Conclusion: The key to the pharmacological treatment of Chronic HF is to address the different pathophysiological mechanisms involved in HF, through 4 pharmacological groups such as: ACEI or ARA-II/IN, Beta Blockers, Mineralocorticoid Receptor Antagonists and Sodium-glucose cotransporter-2 (SGLT2) inhibitor, which are currently considered first-line in treatment.